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Objective: Alterations in chondrocyte differentiation and matrix remodeling play a central role in
osteoarthritis (OA). Chondrocyte differentiation and remodeling are amongst others regulated by the
so-called Bone Morphogenetic Proteins (BMPs). Although BMPs are considered protective for articular
cartilage these factors can also be involved in chondrocyte hypertrophy and matrix degradation. This
review is focused on these opposed roles of BMPs in OA development and progression.
Methods: Peer reviewed publications published prior to August 2009 were searched in the Pubmed
database. Articles that were relevant for the role of endogenous BMPs in OA were selected. Since good
quality reviews on the application of BMP supplementation in cartilage tissue engineering have been
described this subject has not been covered in this review.
Results: BMPs can stimulate both chondrocyte matrix synthesis and chondrocyte terminal differentiation.
The latter results in elevated matrix metalloproteinase-13 (MMP-13) production. Stimulation of matrix
synthesiswill be protective for cartilagewhile elevatedMMP-13 activitywill drivematrix degradation.What
action of BMPs is dominant in OA is not yet elucidated and their rolemight be different in patient subgroups.
Conclusion: BMPs can be protective for articular cartilage but can, due to their effect on chondrocyte
differentiation, have harmful effects on articular cartilage and contribute to OA progression.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The mammalian genome encodes over 40 different members of
the transforming growth factor-b superfamily. The largest
subfamily are the Bone Morphogenetic Proteins (BMPs). BMP
activity was ﬁrst identiﬁed in the early sixties but elucidation of the
proteins responsible for the bone-inductive action was not ach-
ieved before the eighties1. Nowadays more than 20 BMPs are
known and these proteins are involved in numerous cellular
functions of which bone formation is just a small part.
The paradigm is that BMPs are protective for articular cartilage.
We postulate that BMPs are not always protective but that BMPs
can play a role in cartilage destruction and osteoarthritis (OA)
progression. A dual role of BMPs in OA provides an explanation for
the enigmatic observation that in OA both cartilage anabolism and
catabolism are elevated. This review portrays the role of BMPs ino: Peter M. van der Kraan,
), Radboud University Nijme-
ﬂoor, Room 2.87, 6525 GA
31-24-3540403.
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s Research Society International. Pcartilage development and how this role can not only be related to
intrinsic cartilage repair but also to cartilage pathology like OA.BMPs and BMP signaling
BMPs are highly conserved proteins and can function inter-
changeable throughout a large part of the animal kingdom, for
example BMPs that function in humans also function in insects2.
Thesemolecules are synthesized and secreted as precursor proteins
and active BMP is only obtained after proteolytic cleavage of the
prodomain3, although the latter has been challenged lately4. BMPs
contain seven conserved cysteine knot domains. Six of those build
an intramolecular cysteine knot, making the molecule relatively
stable and heath resistant, and the seventh is used for intracellular
dimerizationwith another BMP peptide5,6. In general dimers of two
similar molecules are formed but also the formation of hetero-
dimers has been observed7,8.
The mammalian BMPs can be segregated in several groups but
the name giving within and between groups is rather confusing.
BMP subgroups can be recognized based on amino acid sequence
similarities (Table I)9,10. The subgroup containing Growth Differ-
entiation Factor 9 (GDF9) and BMP-15 is more related to nodal than
to the other BMPs while BMP-11 (GDF11) is related to the TGFublished by Elsevier Ltd. All rights reserved.
Table I
Division of BMPs in separate groups based on amino acid similarity9
Subgroup BMP members Remarks
BMP-2/4 BMP-2, BMP-4
BMP-7 BMP-5, BMP-6, BMP-7, BMP-8
BMP-3 BMP-3, GDF10
GDF5 GDF5, GDF6, GDF7
BMP-9 BMP-9, BMP-10 Related to the GDF5 subgroup
GDF1 GDF1, GDF3
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does not directly regulate the growth and differentiation of cells but
can modulate the activity of TGF beta superfamily members10,11. All
BMPs, except BMP-1, regulate cell function by binding to speciﬁc
membrane-bound receptors. In this review we restrict to the BMPs
in Table I.
The main BMP signaling route is by means of speciﬁc,
membrane-associated, type I and type II serine/threonine kinase
receptors and their intracellular effectors, but other signaling
routes also have been described, such as via TAK112,13. BMPs binds
to a type II receptor with constitutive kinase activity after which
a type I receptor is recruited (Fig. 1). The type I receptor phos-
phorylates so-called receptor Smads (R-Smads). A complex of two
receptor Smads and one common Smad (Smad4) is formed that
migrates to the nucleus to modulate gene expression. Three type II
receptors have been identiﬁed that bind BMP ligands; the type II
BMP receptor (BMPR-II), the type II and IIB activin receptors (ActR-II
and ActR-IIB)14,15. Four type I receptors for BMPs have been char-
acterized, known as ALK1, 2, 3 and 616e23. These ALKs all signal via
Smad1, 5 or 8 as receptor Smads. The type II and type I receptors do
not bind all ligands with similar efﬁciency and different ligands
make use of different combinations of type I and II receptors to
signal.
The BMPs have been given their name for their role in bone
induction and BMP signaling is considered to be essential for
endochondral bone formation. An intermediate in this process of
bone formation is cartilage. Since cartilage is the main tissue
affected in OA and chondrocytes are considered to be crucial in OA
the role of BMPs in chondrocyte differentiation will be discussed.Fig. 1. Simpliﬁed scheme of the Smad-dependent BMP signaling cascade. BMPs bind
the BMP-RI and R-II receptors. Four BMP-RI receptors are known, ALK1, 2, 3 or 6
while three BMP-R-II receptors have been identiﬁed. The type II BMP receptor (BMPR-
II), the type II and IIB activin receptors (ActR-II and ActR-IIB). The type II receptor
phosphorylates the type I receptor and subsequently the type I receptor activates the
receptor Smads, Smad1, 5 or 8. After binding of the receptor Smads to Smad4 this
complex shuttles to the nucleus and modulates gene expression.BMPs and chondrocyte differentiation
Cartilage development (chondrogenesis), as it can be observed
amongst others in the developing embryo, the formation of
osteophytes and fracture repair, is a strictly regulated process24.
Mesenchymal precursor cells condensate and switch on chondro-
genic differentiation. Differentiation of prechondrocytes into
differentiated chondrocytes goes through a phase characterized by
high cell proliferation and deposition of cartilage speciﬁc mole-
cules, such as type II collagen and aggrecan. In the growth plate, the
phase of differentiated chondrocytes is followed by chondrocyte
terminal differentiation and endochondral ossiﬁcation. During
terminal differentiation chondrocytes become hypertrophic, char-
acterized by cell enlargement and expression of type X collagen and
MMP-13. Hypertrophic chondrocytes die by apoptosis and are
ﬁnally replaced by bone. Alternatively, development of permanent
articular cartilage at the end of the long bones is characterized by
blocking terminal differentiation by, an until now, unknown
mechanism. However, during OA, part of the chondrocytes in
articular cartilage lose their stable phenotype and undergo changes
that remind us of the alterations that normally only take place in
terminally differentiating chondrocytes.
BMPs are involved in all phases of chondrogenesis and BMPs
directly regulate the expression of several chondrocyte speciﬁc
genes25e27. BMP activity is indispensable for correct cartilage
formation. Blocking BMP activity by the use of noggin inhibits
condensation of mesenchymal cells and the formation of chon-
drogenic aggregates28. The BMP-induced chondrogenic differenti-
ation appears to be mediated through gap junction-mediated
intercellular communication29.
BMPs not only stimulate condensation but have a strong effect
on chondrocyte proliferation and matrix synthesis24,30. In growth
plate chondrocytes BMP-2, -4 and -5 up-regulated cell proliferation
and matrix production31,32. In developing mouse limbs BMP-2 and
BMP-7 enhanced cell proliferation and expression of type II
collagen mRNA33,34. In cultured human normal articular ankle
chondrocytes BMP-2, -4, and -7 stimulated aggrecan synthesis35.
BMP activity has been demonstrated to regulate expression and
activity of a transcription factor essential in chondrogenesis,
sox927,36. BMP-2 overexpression resulted in accelerated up-regu-
lation of sox9 gene expression in murine bone fractures indicating
that enhancement of chondrogenesis by BMP-2 is mediated via
a sox9-dependent pathway37. However, BMP activity not only
elevates sox9 expression but also stimulates the chondrogenic
capacity of sox9 by forming a sox9eCREB complex and promoting
DNA binding26,27.
Although BMPs signal not solely via the Smad pathway, the
canonical Smad pathway has been demonstrated to be vital for
endochondral bone formation. In growth plates of rats Smad1 and
Smad5 were highly expressed in proliferating chondrocytes and
chondrocytes that underwent maturation. Retting et al. showed
that deletion of individual Smads (1, 5 and 8) in a cartilage speciﬁc
fashion resulted in viable and fertile mice while combined loss of
Smads 1, 5 and 8 led to severe chondrodysplasia38. Mice without
Smad1 and Smad8 or Smad5 and Smad8 appeared to be normal.
Smad8 has aminor role in chondrogenesis while Smad1 and Smad5
are essential but interchangeable. Moreover, mice knock out for
Smad1 and Smad8 and with only one functional allele of Smad5
were normal. Remarkably, the Smad1/5 knock out phenotype is
more severe than that of Smad4 knock out mice, challenging the
doctrine, at least in chondrocytes, that Smad4 is critical for Smad
signaling through BMP pathways38.
Chondrocyte differentiation during endochondral bone forma-
tion appears to be controlled by Smad1 or Smad5 but also the
transcription factor Runx2 plays an essential part in this process. In
P.M. van der Kraan et al. / Osteoarthritis and Cartilage 18 (2010) 735e741 737mice that lack Runx2 chondrocyte terminal differentiation is totally
blocked and these animals show no bone formation39. It is thought
that Smads cooperate with Runx2 to control chondrocyte terminal
differentiation and that Runx2 and Smad1 or 5 are essential38,40e45.
Data indicate that the Smads undergo a physical interaction with
Runx2 to render Runx2 functional in stimulating endochondral
differentiation44,45. Interaction of Runx2 with Smad1 or Smad5 has
been shown to stimulate terminal differentiation of pre-hypertro-
phic chondrocytes42,43. In conclusion, chondrocyte terminal
differentiation is stimulated by signaling via Smad1 or 5.
Locally produced BMPs, BMP inhibitors and cartilage
homeostasis
The application of BMP supplementation to stimulate chon-
drogenesis and cartilage repair is well known and this is compre-
hensively discussed in a number of excellent reviews46e49. Less is
known about the role of endogenously produced BMPs in healthy
and diseased articular cartilage. We hypothesize that this role can
have two faces; a role in maintenance of cartilage homeostasis and
a role in accelerating cartilage autodestruction and OA.
Several BMPs have been detected in normal and diseased
cartilage. Chen et al. reported mRNA expression of BMP-2, 4e6, 11
and GDF5 in normal and osteoarthritic adult human cartilage50 and
BMP-6was detected in both osteoarthritic and normal adult human
articular cartilage by Bobacz et al.51. However, others reported that
BMP-2 was hardly present in normal human articular cartilage
while in osteoarthritic cartilage BMP-2 mRNA and protein
were clearly detected in both clustering and individual chon-
drocytes52,53. In isolated human chondrocytes, IL-1beta and TNF-
alpha increased BMP-2 mRNA and protein levels and mechanical
injury of human cartilage explants resulted in increased expression
of BMP-253,54. In mouse models of OA we detected strong up-
regulation of BMP-2 and BMP-4 neighboring cartilage lesions.
Limited data are available about the role of locally produced
BMPs in the protection against cartilage damage or stimulation of
repair processes. Locally produced BMPs may play an important
role in protection and regeneration of cartilage during and after
inﬂammatory or traumatic damage or in osteoarthritic cartilage55.
In experimental arthritis overexpression of the BMP inhibitor
noggin resulted in increased cartilage damage while noggin hap-
loinsufﬁciency protected articular cartilage against destruction56.
We have found that blocking intrinsic BMP activity after an intra-
articular IL-1-challenge using gremlin resulted in decreased
aggrecan synthesis compared with IL-1 alone. Moreover, blocking
BMP activity aggravated proteoglycan depletion showing that BMPs
contributes to the intrinsic repair capacity of damaged cartilage57.
These studies indicate that BMP activity is induced by inﬂammatory
mediators and can play a role in enhancing cartilage repair and/or
protection against cartilage damage. However, the observed BMP
effects in these models might be mainly based on boosting the
synthesis of matrixmolecules such as aggrecan and type II collagen,
the role that BMPs might have in modulating articular chondrocyte
phenotype, and in this way on cartilage integrity, are not taken into
account.
The activity of BMPs is controlled by a number of, more or less,
speciﬁc inhibitors of which several have been detected in articular
cartilage. Expression of the inhibitors noggin and follistatin has
been detected in fetal, adult and osteoarthritic cartilage50.
However, Tardif and coworkers detected expression of gremlin,
chordin, and follistatin by human chondrocytes but no expression
of noggin. Follistatin and gremlin were signiﬁcantly up-regulated
in OA chondrocytes compared to normal chondrocytes58. In
a histochemical study these authors reported low levels of folli-
statin and gremlin in normal cartilage and up-regulation of bothproteins in cartilage of patients with advanced OA disease
progression59. Activity of BMPs is not only controlled in the
extracellular space but also intracellular. The intracellular inhibi-
tors Smad6 and Smad7 are expressed, on mRNA and protein level,
in normal and OA human cartilage but no changes were found in
early or late OA cartilage60. It is not clear to what extend locally
produced BMP inhibitors will control BMP activity in normal and
OA cartilage. An elevated ratio of BMPs to inhibitors will increase
BMP activity and will stimulate chondrocyte differentiation while
a low ratio might impair synthesis of matrix molecules. How this
ratio changes in OA cartilage and how this will affect the disease
process is not identiﬁed yet.
Dual role of BMPs in OA
Chondrocyte differentiation is a carefully regulated process as
discussed above. In the growth plate chondrogenesis is followed by
chondrocyte terminal differentiation and endochondral ossiﬁca-
tion. During terminal differentiation chondrocytes become hyper-
trophic and remove the collagen matrix through the production of
MMP-1361e63. Finally hypertrophic chondrocytes die by apoptosis
and are replaced by bone. In the formation of articular cartilage
terminal differentiation is prevented which results in permanent
cartilage residing at the end of the long bones. However, during OA,
chondrocytes in articular cartilage undergo phenotypic changes
that bear resemblance to the alteration that occur in terminally
differentiating chondrocytes, such as high MMP-13 synthesis64,65.
BMPs are involved in all phases of chondrogenesis; mesen-
chymal condensation, chondrocyte proliferation, extracellular
matrix deposition and ﬁnally terminal differentiation. BMP
activity boosts all phases of chondrocyte differentiation26,38,66e70.
Signaling via the so-called BMP-related receptor Smads is strictly
required for chondrocyte terminal differentiation. Loss of both
Smad1 and 5 leads to blockage of chondrocyte terminal differ-
entiation and severe cartilage defects38. Mice overexpressing
inhibitors of the Smad1/5/8 signaling route, Smad6 or Smurf1,
show regular chondrocytes proliferation but blocked chondrocyte
terminal differentiation71. Moreover, Smad6 inhibition with an
antisense morpholino in differentiating chicken chondrocytes
enhanced terminal differentiation, whereas overexpression of
Smad6 blocked BMP-2-induced chondrocyte hypertrophy72. These
results clearly indicate that BMP activity drives chondrocyte
terminal differentiation.
The direct, short term, effects of BMPs on MMP-13 expression
are not straightforward, we (unpublished observation) and others
have found stimulation of MMP-13 expression in chondrocytes but
also inhibition or no effect has been reported. In normal and
osteoarthritic human chondrocytes, stimulation with BMP-7 did
not result in signiﬁcant changes in MMP-13 expression73. On the
other hand, in immortalized mouse chondrocytes stimulation with
BMP-2 followed by IL-1 exposure led to increased expression of
MMP-1374. In chondrosarcoma cells BMP-2 increased the expres-
sion and secretion of MMP-13 but inhibition of MMP-13 expression
was found in fetal rat calvarial osteoblasts75e77. In C2C12 osteo-
blasts stably expressing canonical Wnt3a, exposure to BMP-2
resulted in elevated MMP-13 expression78. Not unexpectedly, long
term culture of chondrocytes in the presence of BMP-2 has been
shown to markedly up-regulate the expression of MMP-13. Chon-
drocyte-culture-derived tissue that was stimulated with BMP-2
was more frail than tissue cultured without BMP-279. Apparently,
although the short term effects of BMP activity are not clear-cut, the
long term effects appear to point to elevated MMP-13 levels as
a result of modulation of the chondrocyte phenotype.
BMP activity can stimulate the synthesis ofmatrixmolecules but
can also elevate MMP-13 expression by modulation of chondrocyte
Chondroprogenitor cells
OA?
hypertrophic chondrocyteschondrocytes
++ ++
Type I collagen Type X collagen – MMP13  Type II, IX, XI collagen 
cartilage formation/repair hypertrophy/osteoarthritis
Fig. 2. BMPs play several roles in chondrogenesis and chondrocyte differentiation.
BMPs stimulate condensation of chondrocyte precursors and stimulate chondrocyte
proliferation and matrix synthesis. In addition, BMPs strongly stimulate chondrocyte
terminal differentiation (hypertrophy). BMPs are not only important in cartilage
formation and repair but can also be expected to be players in OA development and
progression.
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example as type II collagen, and elevated MMP-13 expression are
characteristics of OA cartilage80e82. Elevated BMP levels in
damaged cartilage can on one side contribute to tissue repair by
boosting matrix synthesis but on the other side stimulate cartilage
degeneration by altering chondrocyte behavior and stimulating
MMP-13 expression. It can be expected that different BMPs will
have different effects in this process. It becomes more and more
clear that, by binding to different receptor combinations and
consequently activating different intracellular signaling routes,
different BMPs can have differential effects on cells. For example,
while most BMPs stimulate bone formation, BMP-3 acts as a nega-
tive regulator of bone formation83. Minor differences in BMP
structure can regulate the speciﬁcity of ligandereceptor binding
and alter biological function84. Moreover, alterations in BMP
receptor expression during aging and OA, as reported for TGF-b
receptors85,86, will change the biological effects of BMPs on their
target cells.
In conclusion, BMP activity can stimulate both chondrocyte
matrix synthesis and MMP-13 production (Fig. 2). What action of
BMPs dominates in the OA process is not known and might be
different between different patients and OA subtypes. Overall,
BMPs and other members of the TGF-b superfamily, can be
protective for articular cartilage but can also have a harmful role
depending on changes in the biological context, such as for instance
occur during aging. Future research into the role of these fasci-
nating proteins in both OA progression and OA protection will
provide indications for either supplementation or inhibition of
speciﬁc BMPs, or their various signaling pathways, to treat OA.Conﬂicts of interest
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